These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29674947)

  • 21. Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden.
    Neicun J; Steenhuizen M; van Kessel R; Yang JC; Negri A; Czabanowska K; Corazza O; Roman-Urrestarazu A
    PLoS One; 2019; 14(6):e0218011. PubMed ID: 31242225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price.
    Brunt TM; Atkinson AM; Nefau T; Martinez M; Lahaie E; Malzcewski A; Pazitny M; Belackova V; Brandt SD
    Int J Drug Policy; 2017 Jun; 44():105-114. PubMed ID: 28472731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring novel psychoactive substances allegedly offered online for sale in Persian and Arabic languages.
    Corazza O; Assi S; Malekianragheb S; Beni MN; Bigdeli I; Aslanpour Z; Schifano F
    Int J Drug Policy; 2014 Jul; 25(4):724-6. PubMed ID: 24917190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug Use Changes at the Individual Level: Results from a Longitudinal, Multisite Survey in Young Europeans Frequenting the Nightlife Scene.
    Grabski M; Waldron J; Freeman TP; Mokrysz C; van Beek RJJ; van der Pol P; Hauspie B; Dirkx N; Schrooten J; Elgán TH; Feltman K; Benedetti E; Scalia Tomba G; Fabi F; Molinaro S; Gripenberg J; van Havere T; van Laar M; Curran HV
    Eur Addict Res; 2022; 28(2):155-160. PubMed ID: 34839293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The challenge of complex drug use: Associated use of codeine-containing medicines and new psychoactive substances in a European cross-sectional online population.
    Kimergård A; Foley M; Davey Z; Wadsworth E; Drummond C; Deluca P
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28597537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
    Palamar JJ; Martins SS; Su MK; Ompad DC
    Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016.
    Deen AA; Claridge H; Treble RD; Hamnett HJ; Copeland CS
    J Psychopharmacol; 2021 Nov; 35(11):1315-1323. PubMed ID: 34182812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Psychoactive Substances (NPS) - a Challenge for the Addiction Treatment Services.
    Scherbaum N; Schifano F; Bonnet U
    Pharmacopsychiatry; 2017 May; 50(3):116-122. PubMed ID: 28444659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.
    Zawilska JB
    Int Rev Neurobiol; 2015; 120():273-300. PubMed ID: 26070762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations.
    Soussan C; Kjellgren A
    Int J Drug Policy; 2016 Jun; 32():77-84. PubMed ID: 27184218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment.
    Specka M; Kuhlmann T; Sawazki J; Bonnet U; Steinert R; Cybulska-Rycicki M; Eich H; Zeiske B; Niedersteberg A; Schaaf L; Scherbaum N
    Front Psychiatry; 2020; 11():569. PubMed ID: 32733288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives.
    Soussan C; Andersson M; Kjellgren A
    Int J Drug Policy; 2018 Feb; 52():71-78. PubMed ID: 29241144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.
    Mohr ALA; Logan BK; Fogarty MF; Krotulski AJ; Papsun DM; Kacinko SL; Huestis MA; Ropero-Miller JD
    J Anal Toxicol; 2022 Jul; 46(6):e116-e185. PubMed ID: 35445267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No Good Time Without Drugs: Qualitative Study Among Nightlife Attendees in Tbilisi, Georgia.
    Kirtadze I; Mgebrishvili T; Beselia A; Gvasalia T; Chokheli M; Ompad DC; Otiashvili D
    Adiktologie; 2022; 22(3):152-160. PubMed ID: 36405630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013-2015.
    Smith KE; Bunting AM; Staton M; Walker R; Shalash S; Winston E; Pangburn K
    J Psychoactive Drugs; 2017; 49(5):436-445. PubMed ID: 28813207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics of new psychoactive substances: A multicenter study.
    Chen TH; Chen HY; Lin CC; Liu SW; Weng TI; Fang CC; Yu JH; Chen YC; Su YJ
    J Forensic Leg Med; 2023 Jan; 93():102469. PubMed ID: 36571928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional employment and individual worklessness during the Great Recession and the health of the working-age population: Cross-national analysis of 16 European countries.
    Niedzwiedz CL; Thomson KH; Bambra C; Pearce JR
    Soc Sci Med; 2020 Dec; 267():112377. PubMed ID: 31285070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candyflipping and Other Combinations: Identifying Drug-Drug Combinations from an Online Forum.
    Chary M; Yi D; Manini AF
    Front Psychiatry; 2018; 9():135. PubMed ID: 29760666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How to ask about the use of new psychoactive substances to increase the validity of results in self-report prevalence surveys.
    Drapalova E; Belackova V; Cadet-Taïrou A
    Drug Alcohol Rev; 2020 Mar; 39(3):278-286. PubMed ID: 32078202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014-2019.
    Crulli B; Dines AM; Blanco G; Giraudon I; Eyer F; Liechti ME; Miró Ò; Hovda KE; Heyerdahl F; Yates C; Vallersnes OM; Wood DM; Dargan PI;
    Clin Toxicol (Phila); 2022 Dec; 60(12):1318-1327. PubMed ID: 36322684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.